Home Overview Press Room Blog Publications For Students about us
Search

News Article

Stem cell industry's 'huge development' in Bay Areaby Stephanie M. LeeSan Francisco ChronicleAugust 29th, 2014Almost three years after Geron shut down the world's first clinical trial of a therapy using embryonic stem cells, Asterias, a subsidiary of the Alameda company BioTime, has permission to test for clinical efficacy.
Using Light Technique, Scientists Find Dimmer Switch for Memories in Miceby Pam BelluckThe New York TimesAugust 27th, 2014Using a technique in which light is used to switch neurons on and off, neuroscientists at the Massachusetts Institute of Technology appear to have unlocked some secrets about how the brain attaches emotions to memories and how those emotions can be adjusted.
Stem cell therapy a primitive artby Jill MargoFinancial ReviewAugust 27th, 2014A loophole in Australian regulations means people can be given stem cell therapy for virtually anything providing their own stem cells are harvested then used in the process, but much can go wrong.
British baby Gammy: Surrogate claims mum refused to take disabled twinby Ellen WallworkParentDishAugust 26th, 2014A British surrogate mother of twins has said the intended mother rejected one of the babies because she was born with a disability.
Thailand’s Business in Paid Surrogates May Be Foundering in a Moral Quagmireby Thomas FrankThe New York TimesAugust 26th, 2014The baby boomlet in Pak Ok was just one of several bizarre and often ethically charged iterations of Thailand’s freewheeling venture into what detractors call the womb rental business, an unguided experiment that the country’s military government now says it is planning to end.
Medical dilemma of 'three-parent babies': Fertility clinic investigates health of teenagers it helped to be conceived through controversial IVF techniqueby Steve ConnorThe Independent (UK)August 25th, 2014A private fertility clinic in the United States has launched an investigation into the health of 17 teenagers who were born as a result of a controversial IVF technique that produced the world’s first “three-parent” embryos more than 15 years ago.
Will Lowering The Price Of Genetic Testing Raise The Cost Of Medical Care?by Peter UbelForbesAugust 25th, 2014The days of affordable genomic sequencing are rapidly approaching. But will such testing bankrupt us?
Stem Cell Therapy Rogue Operators Charging Thousands for Useless or Dangerous Treatmentby Louise MilliganABCAugust 25th, 2014Rogue stem cell therapy operators are charging tens of thousands of dollars for treatments that are ineffectual or could even lead to more health problems and death, according to Australia's leading group of stem cell scientists.
Not-So-Personalized Medicine by Howard BrodyHooked: Ethics, Medicine, and PharmaAugust 23rd, 2014Personalized medicine may increasingly be useful in particular situations, but potential limits include false genetic determinism, high costs, and low predictive accuracy.
Interpol Investigates 'Baby Factory' as Man Fathers 16 Surrogate Childrenby Kevin RawlinsonThe GuardianAugust 23rd, 2014Interpol has launched an investigation into an alleged "baby factory" after it emerged that a Japanese businessman had fathered 16 surrogate children and expressed a desire for many more.
Displaying 1-10 of 3274  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760